Compare Stocks: RCEL, IART, AORT, and PRCT

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AORT Artivion	$25.13 +1.9%	$26.27	$19.16 ▼ $48.25	$1.22B	1.25	603,561 shs	547,889 shs
IART Integra LifeSciences	$15.50 -0.3%	$17.59	$8.70 ▼ $20.49	$1.21B	1.21	598,248 shs	792,026 shs
PRCT PROCEPT BioRobotics	$20.38 +1.5%	$20.24	$16.67 ▼ $40.10	$1.17B	0.91	924,609 shs	1.57 million shs
RCEL Avita Medical	$9.88 +0.2%	$7.27	$3.22 ▼ $11.39	$304.08M	2.02	350,917 shs	225,202 shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AORT Artivion	0.00%	-1.81%	-11.76%	+25.40%	-38.68%
IART Integra LifeSciences	0.00%	-7.30%	-15.02%	-12.77%	+0.71%
PRCT PROCEPT BioRobotics	0.00%	-10.46%	-7.15%	-20.70%	-45.65%
RCEL Avita Medical	0.00%	-11.79%	+23.35%	+152.69%	+136.93%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AORT Artivion	$25.13 +1.9%	$26.27	$19.16 ▼ $48.25	$1.22B	1.25	603,561 shs	547,889 shs
IART Integra LifeSciences	$15.50 -0.3%	$17.59	$8.70 ▼ $20.49	$1.21B	1.21	598,248 shs	792,026 shs
PRCT PROCEPT BioRobotics	$20.38 +1.5%	$20.24	$16.67 ▼ $40.10	$1.17B	0.91	924,609 shs	1.57 million shs
RCEL Avita Medical	$9.88 +0.2%	$7.27	$3.22 ▼ $11.39	$304.08M	2.02	350,917 shs	225,202 shs

7 Energy Stocks to Buy and Hold Forever

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AORT Artivion	0.00%	-1.81%	-11.76%	+25.40%	-38.68%
IART Integra LifeSciences	0.00%	-7.30%	-15.02%	-12.77%	+0.71%
PRCT PROCEPT BioRobotics	0.00%	-10.46%	-7.15%	-20.70%	-45.65%
RCEL Avita Medical	0.00%	-11.79%	+23.35%	+152.69%	+136.93%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AORT Artivion	2.75	Moderate Buy	$44.83	78.42% Upside
IART Integra LifeSciences	1.88	Reduce	$18.86	21.66% Upside
PRCT PROCEPT BioRobotics	2.19	Hold	$25.09	23.12% Upside
RCEL Avita Medical	2.57	Moderate Buy	$11.40	15.38% Upside

Current Analyst Ratings Breakdown

Latest RCEL, IART, AORT, and PRCT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/9/2026	PRCT PROCEPT BioRobotics	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Market Perform
8/28/2026	RCEL Avita Medical	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$8.00 ➝ $12.00
8/19/2026	RCEL Avita Medical	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$12.00 ➝ $14.00
8/19/2026	RCEL Avita Medical	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$7.00 ➝ $11.00
8/18/2026	AORT Artivion	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$39.00 ➝ $40.00
8/14/2026	IART Integra LifeSciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/11/2026	AORT Artivion	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D+) ➝ Sell (D-)
8/7/2026	AORT Artivion	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$39.00
8/7/2026	RCEL Avita Medical	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$7.00
8/5/2026	PRCT PROCEPT BioRobotics	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$34.00 ➝ $28.00
8/5/2026	PRCT PROCEPT BioRobotics	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$21.00

(Data available from 9/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AORT Artivion	$441.33M	2.78	$1.10 per share	22.76	$9.46 per share	2.66
IART Integra LifeSciences	$1.64B	0.74	$4.22 per share	3.67	$13.40 per share	1.16
PRCT PROCEPT BioRobotics	$308.05M	3.79	N/A	N/A	$6.55 per share	3.11
RCEL Avita Medical	$71.61M	4.25	N/A	N/A	($0.55) per share	-17.96

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AORT Artivion	$9.77M	-$0.07	N/A	32.63	N/A	-0.67%	6.07%	2.93%	11/5/2026 (Estimated)
IART Integra LifeSciences	-$516.47M	-$0.09	N/A	6.03	0.80	-0.44%	18.30%	5.30%	10/29/2026 (Estimated)
PRCT PROCEPT BioRobotics	-$95.57M	-$1.94	N/A	N/A	N/A	-32.53%	-30.62%	-22.10%	11/3/2026 (Estimated)
RCEL Avita Medical	-$48.59M	-$1.44	N/A	N/A	N/A	-56.96%	N/A	-78.53%	11/5/2026 (Estimated)

Latest RCEL, IART, AORT, and PRCT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q2 2026	AORT Artivion	$0.0025	$0.13	+$0.1275	-$0.28	$119.99 million	$125.76 million
8/6/2026	Q2 2026	RCEL Avita Medical	-$0.2928	-$0.25	+$0.0428	-$5.00	$20.25 million	$21.70 million
8/4/2026	Q2 2026	PRCT PROCEPT BioRobotics	-$0.4619	-$0.47	-$0.0081	-$0.47	$92.77 million	$94.50 million
7/29/2026	Q2 2026	IART Integra LifeSciences	$0.4805	$0.56	+$0.0795	$0.06	$417.54 million	$418.76 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AORT Artivion	N/A	N/A	N/A	N/A	N/A
IART Integra LifeSciences	N/A	N/A	N/A	N/A	N/A
PRCT PROCEPT BioRobotics	N/A	N/A	N/A	N/A	N/A
RCEL Avita Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AORT Artivion	0.82	3.47	2.51
IART Integra LifeSciences	1.75	3.60	2.11
PRCT PROCEPT BioRobotics	0.15	6.55	5.35
RCEL Avita Medical	N/A	0.41	0.34

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AORT Artivion	86.37%
IART Integra LifeSciences	84.78%
PRCT PROCEPT BioRobotics	89.46%
RCEL Avita Medical	27.66%

Insider Ownership

Company	Insider Ownership
AORT Artivion	6.30%
IART Integra LifeSciences	3.84%
PRCT PROCEPT BioRobotics	4.00%
RCEL Avita Medical	2.24%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AORT Artivion	1,800	48.76 million	45.68 million	Optionable
IART Integra LifeSciences	4,427	77.77 million	74.79 million	Optionable
PRCT PROCEPT BioRobotics	888	57.27 million	54.98 million	Optionable
RCEL Avita Medical	130	30.78 million	30.09 million	Optionable

RCEL, IART, AORT, and PRCT Headlines

Recent News About These Companies

Avita Medical Inc. (NASDAQ:RCEL) Given Average Recommendation of "Moderate Buy" by Analysts

September 13 at 2:14 AM | americanbankingnews.com

Avita Medical Inc. (NASDAQ:RCEL) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

September 13 at 2:13 AM | marketbeat.com

564,952 Shares in Avita Medical Inc. $RCEL Bought by BlackRock Inc.

September 6, 2026 | marketbeat.com

RCEL stock gains on fresh price data while Avita Medical readies next steps

September 5, 2026 | ad-hoc-news.deA

AVITA Medical to Participate in Lake Street Best Ideas Growth Conference and Morgan Stanley Healthcare Conference

September 2, 2026 | globenewswire.com

All You Need to Know About Avita Medical (RCEL) Rating Upgrade to Buy

August 31, 2026 | zacks.com

Avita Medical Inc. (RCEL) is a Great Momentum Stock: Should You Buy?

August 24, 2026 | zacks.com

AVITA Medical: Favorable Reimbursements For Skin Wound Care

August 24, 2026 | seekingalpha.com

AVITA Medical (NASDAQ:RCEL) Raises Full-Year Guidance on Spray-On Skin Adoption

August 19, 2026 | kalkinemedia.comK

Avita Medical PermeaDerm Study Shows 70% Cost Reduction vs. Allograft

August 19, 2026 | marketbeat.com

Avita Medical Inc. (NASDAQ:RCEL) Receives Average Rating of "Moderate Buy" from Analysts

August 19, 2026 | marketbeat.com

Avita Medical Says PermeaDerm Study Meets Primary Endpoint, Showing 70% Cost Reduction

August 18, 2026 | finance.yahoo.com

AVITA rises as wound care product succeeds in US burn center trial

August 18, 2026 | msn.com

AVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable Clinical Outcomes

August 18, 2026 | globenewswire.com

Avita Medical Raises 2026 Revenue Outlook as Q2 Sales Climb 18%

August 16, 2026 | marketbeat.com

Avita Medical Targets Q4 2025 Cash Flow Breakeven as Revenue Growth Builds

August 16, 2026 | marketbeat.com

AVITA Medical (RCEL) Q2 2026 Earnings Call Transcript

August 13, 2026 | finance.yahoo.com

AVITA Medical to Host Investor Webinar Briefing

August 9, 2026 | globenewswire.com

AVITA Medical Reports Second Quarter Results, Raises 2026 Revenue Guidance, and Expects Fourth Quarter Cash Flow Breakeven

August 7, 2026 | markets.businessinsider.com

Avita Medical shares surge after record second-quarter performance

August 7, 2026 | msn.com

AVITA Medical Announces Participation at Canaccord Genuity Growth Conference

August 7, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

RCEL, IART, AORT, and PRCT Company Descriptions

Artivion NYSE:AORT

$25.13 +0.48 (+1.94%)

Closing price 09/11/2026 03:58 PM Eastern

Extended Trading

$25.08 -0.05 (-0.19%)

As of 09/11/2026 07:30 PM Eastern

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts including E-vita Open Plus and E-vita Open Neo. It offers E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, a stent graft system for the treatment of infrarenal abdominal aortic aneurysms. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.

Integra LifeSciences NASDAQ:IART

$15.50 -0.04 (-0.26%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$15.50 0.00 (0.00%)

As of 09/11/2026 07:30 PM Eastern

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

PROCEPT BioRobotics NASDAQ:PRCT

$20.38 +0.31 (+1.54%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$20.76 +0.39 (+1.89%)

As of 09/11/2026 07:30 PM Eastern

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Avita Medical NASDAQ:RCEL

$9.88 +0.02 (+0.20%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$10.18 +0.30 (+3.04%)

As of 09/11/2026 07:54 PM Eastern

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest RCEL, IART, AORT, and PRCT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest RCEL, IART, AORT, and PRCT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

RCEL, IART, AORT, and PRCT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

RCEL, IART, AORT, and PRCT Company Descriptions

Artivion NYSE:AORT

Integra LifeSciences NASDAQ:IART

PROCEPT BioRobotics NASDAQ:PRCT

Avita Medical NASDAQ:RCEL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest RCEL, IART, AORT, and PRCT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest RCEL, IART, AORT, and PRCT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

RCEL, IART, AORT, and PRCT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

RCEL, IART, AORT, and PRCT Company Descriptions

Artivion NYSE:AORT

Integra LifeSciences NASDAQ:IART

PROCEPT BioRobotics NASDAQ:PRCT

Avita Medical NASDAQ:RCEL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools